Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.62 billion. The enterprise value is $5.70 billion.
| Market Cap | 5.62B |
| Enterprise Value | 5.70B |
Important Dates
The last earnings date was Friday, October 23, 2026, before market open.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | Dec 31, 2026 |
Share Statistics
Balchem has 31.78 million shares outstanding. The number of shares has decreased by -1.58% in one year.
| Current Share Class | 31.78M |
| Shares Outstanding | 31.78M |
| Shares Change (YoY) | -1.58% |
| Shares Change (QoQ) | -0.52% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 92.12% |
| Float | 31.69M |
Valuation Ratios
The trailing PE ratio is 33.40 and the forward PE ratio is 29.38. Balchem's PEG ratio is 3.09.
| PE Ratio | 33.40 |
| Forward PE | 29.38 |
| PS Ratio | 5.07 |
| Forward PS | 4.72 |
| PB Ratio | 4.25 |
| P/TBV Ratio | 15.12 |
| P/FCF Ratio | 31.60 |
| P/OCF Ratio | 25.13 |
| PEG Ratio | 3.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.50, with an EV/FCF ratio of 32.03.
| EV / Earnings | 33.37 |
| EV / Sales | 5.14 |
| EV / EBITDA | 20.50 |
| EV / EBIT | 24.83 |
| EV / FCF | 32.03 |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.47 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 0.80 |
| Interest Coverage | 28.75 |
Financial Efficiency
Return on equity (ROE) is 13.02% and return on invested capital (ROIC) is 12.67%.
| Return on Equity (ROE) | 13.02% |
| Return on Assets (ROA) | 8.53% |
| Return on Invested Capital (ROIC) | 12.67% |
| Return on Capital Employed (ROCE) | 14.91% |
| Weighted Average Cost of Capital (WACC) | 8.83% |
| Revenue Per Employee | $804,192 |
| Profits Per Employee | $123,896 |
| Employee Count | 1,379 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 4.55 |
Taxes
In the past 12 months, Balchem has paid $49.53 million in taxes.
| Income Tax | 49.53M |
| Effective Tax Rate | 22.47% |
Stock Price Statistics
The stock price has increased by +12.72% in the last 52 weeks. The beta is 0.85, so Balchem's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +12.72% |
| 50-Day Moving Average | 171.12 |
| 200-Day Moving Average | 169.03 |
| Relative Strength Index (RSI) | 69.87 |
| Average Volume (20 Days) | 254,782 |
Short Selling Information
The latest short interest is 493,011, so 1.55% of the outstanding shares have been sold short.
| Short Interest | 493,011 |
| Short Previous Month | 620,041 |
| Short % of Shares Out | 1.55% |
| Short % of Float | 1.56% |
| Short Ratio (days to cover) | 2.30 |
Income Statement
In the last 12 months, Balchem had revenue of $1.11 billion and earned $170.85 million in profits. Earnings per share was $5.30.
| Revenue | 1.11B |
| Gross Profit | 404.38M |
| Operating Income | 229.57M |
| Pretax Income | 220.38M |
| Net Income | 170.85M |
| EBITDA | 278.08M |
| EBIT | 229.57M |
| Earnings Per Share (EPS) | $5.30 |
Balance Sheet
The company has $66.26 million in cash and $142.44 million in debt, with a net cash position of -$76.18 million or -$2.40 per share.
| Cash & Cash Equivalents | 66.26M |
| Total Debt | 142.44M |
| Net Cash | -76.18M |
| Net Cash Per Share | -$2.40 |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 41.69 |
| Working Capital | 240.76M |
Cash Flow
In the last 12 months, operating cash flow was $223.82 million and capital expenditures -$45.82 million, giving a free cash flow of $178.00 million.
| Operating Cash Flow | 223.82M |
| Capital Expenditures | -45.82M |
| Depreciation & Amortization | 48.50M |
| Net Borrowing | -30.20M |
| Free Cash Flow | 178.00M |
| FCF Per Share | $5.60 |
Margins
Gross margin is 36.46%, with operating and profit margins of 20.70% and 15.41%.
| Gross Margin | 36.46% |
| Operating Margin | 20.70% |
| Pretax Margin | 19.87% |
| Profit Margin | 15.41% |
| EBITDA Margin | 25.08% |
| EBIT Margin | 20.70% |
| FCF Margin | 16.05% |
Dividends & Yields
This stock pays an annual dividend of $0.40, which amounts to a dividend yield of 0.23%.
| Dividend Per Share | $0.40 |
| Dividend Yield | 0.23% |
| Dividend Growth (YoY) | -58.50% |
| Years of Dividend Growth | 16 |
| Payout Ratio | 7.52% |
| FCF Payout Ratio | 7.11% |
| Buyback Yield | 1.58% |
| Shareholder Yield | 2.12% |
| Earnings Yield | 2.99% |
| FCF Yield | 3.16% |
Analyst Forecast
The average price target for Balchem is $209.25, which is 18.22% higher than the current price. The consensus rating is "Buy".
| Price Target | $209.25 |
| Price Target Difference | 18.22% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 6.69% |
| EPS Growth Forecast (3Y) | 11.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 10.73 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.73 |
| Piotroski F-Score | 7 |